Literature DB >> 10221614

Tumor necrosis factor during pregnancy and at the onset of labor and spontaneous abortion.

S Daher1, F Fonseca, O G Ribeiro, C C Musatti, M Gerbase-DeLima.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the production of tumor necrosis factor (TNF) by peripheral blood cells during pregnancy, at the onset of labor and of spontaneous abortion (SA), as well as in non-pregnant women with and without a history of recurrent spontaneous abortions (RSA). STUDY
DESIGN: The peripheral blood cells TNF production was evaluated in 28 women in the 1st trimester of pregnancy, 21 in the 2nd, and 30 in the 3rd, 47 at term labor; 43, at the onset of SA; 19 healthy and 19 RSA non-pregnant women. The statistical method used was the Mann-Whitney test.
RESULTS: We observed (1) lack of TNF detection in the 1st gestational trimester; (2) increase of TNF production with gestational age, with the highest values being observed at labor (P<0.05); (3) high TNF production at the onset of SA; (4) no difference in the TNF production by healthy and RSA non-pregnant women.
CONCLUSIONS: The suppression of TNF production during the 1st trimester of pregnancy seems to favor the normal development of pregnancy. It remains to be investigated whether the assessment of TNF production is a valuable prognostic parameter for the occurrence of abortion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221614     DOI: 10.1016/s0301-2115(98)00252-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  17 in total

1.  A proposed bio-panel to predict risk for spontaneous preterm birth among African American women.

Authors:  Shannon L Gillespie; Lisa M Christian; Jeremy L Neal
Journal:  Med Hypotheses       Date:  2015-07-31       Impact factor: 1.538

Review 2.  Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective.

Authors:  Tomer Adar; Sorina Grisaru-Granovsky; Ami Ben Ya'acov; Eran Goldin; Ariella Bar-Gil Shitrit
Journal:  Dig Dis Sci       Date:  2015-05-07       Impact factor: 3.199

Review 3.  Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?

Authors:  Guilherme R de Jesús; Gustavo Rodrigues; Nilson R de Jesús; Roger A Levy
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

4.  Adaptation of the inflammatory immune response across pregnancy and postpartum in Black and White women.

Authors:  Shannon L Gillespie; Kyle Porter; Lisa M Christian
Journal:  J Reprod Immunol       Date:  2016-02-10       Impact factor: 4.054

Review 5.  Inflammatory bowel disease and pregnancy: evidence, uncertainty and patient decision-making.

Authors:  Flavio M Habal; Varun Kapila
Journal:  Can J Gastroenterol       Date:  2009-01       Impact factor: 3.522

Review 6.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

7.  Proteomic network analysis of human uterine smooth muscle in pregnancy, labor, and preterm labor.

Authors:  Craig Ulrich; David R Quilici; Karen A Schlauch; Iain L O Buxton
Journal:  Integr Mol Med       Date:  2015-08

Review 8.  Safety of tumour necrosis factor-alpha antagonists.

Authors:  Dinesh Khanna; Maureen McMahon; Daniel E Furst
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  Association of Insulin Resistance with Serum Interleukin-6 and TNF-α Levels During Normal Pregnancy.

Authors:  Abdolreza Sotoodeh Jahromi; Parvin Zareian; Abdolhossein Madani
Journal:  Biomark Insights       Date:  2011-01-12

Review 10.  Molecular mechanisms of preeclampsia.

Authors:  N Vitoratos; D Hassiakos; C Iavazzo
Journal:  J Pregnancy       Date:  2012-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.